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Introduction. In vitro studies on hormone biological activities are commonly performed on 
cells cultured in nominally hormone-free media consisting of phenol-red free media 
supplemented with charcoal-stripped serum. These media are largely used in almost all 
cell types, including endothelial cells. Methods. Cell number and metabolic activity were 
measured with standard methods. Angiogenesis was evaluated in a 3-D spheroid 
sprouting assay. Results. When we compared human umbilical vein endothelial cells 
(HUVECs) cultured in standard conditions (199 medium supplemented with normal serum) 
with HUVECs grown in the hormone-free medium (phenol red-free 199 medium 
supplemented with charcoal-stripped serum), we found that cells stop to grow in the 
absence of hormones. Notably, neither 17-β2 estradiol nor dihydrotestosterone reversed 
this inhibition. Moreover, the presence of the charcoal-stripped serum was sufficient to 
abrogate the ability of HUVECs to sprout in a 3-D spheroid assay, thus affecting a 
functional property of endothelial cells. Conclusions. Our results suggest that one or 
possible more substances removed by stripping procedure from serum and different from 
sex hormones are crucial for the maintenance of in vitro endothelial cell distinctive 
properties. Therefore, caution should be used when endothelial cells are studied in media 
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Atherosclerosis and cardiovascular diseases (CVDs)1 are classical examples of diseases 
where sex/gender differences have been described. A significant body of epidemiological 
evidence suggests that CVDs are less prevalent in women than men until midlife, and the 
female advantage in younger women has been attributed to estrogens, which are lost with 
menopause (1, 2). Since the earliest event in the onset of atherosclerosis and CVDs is 
endothelial dysfunction, i.e. a reduced release of nitric oxide coupled with an increase in 
reactive oxygen species in the vascular wall (3, 4), many studies have been focused on 
endothelium, showing a protective role for estrogens in both in vivo and in vitro models 
(5, 6) where estrogens are able to improve endothelial cell (EC) functions mainly through 
their ability of increasing transcription and activation of the endothelial Nitric Oxide 
Synthase (eNOS) (7-9). 
 To better study the influence of estrogens on metabolic properties of ECs, we 
started some pilot experiments in human umbilical vein ECs (HUVECs) by using an add-
back approach typically adopted to assess in vitro hormone biological activities. 
Essentially, in these reconstitution experiments, sex hormones are added to cells cultured 
in nominally hormone-free media consisting of phenol-red free media supplemented with 
charcoal-stripped (CS) serum. Phenol red is avoided due to its estrogenic activity (10) 
while the stripping procedure depletes the concentration of steroid hormones in serum 
(11, 12). Surprisingly, when we compared HUVECs cultured in standard condition or in the 
hormone-free medium, we found that cells stop to grow in the absence of hormones, and 
neither 17-β2 estradiol (E2) nor dihydrotestosterone (DHT) reversed this effect. In 
addition, the presence of CS serum abrogated the ability of HUVECs to sprout in a 3-
dimensional (3-D) spheroid assay, thus affecting a distinctive property of ECs. Our results 
                                                            
1Abbreviations: bFGF, basic Fibroblast Growth Factor; ChM, charcoal medium; CS, 
charcoal-stripped; CVD, cardiovascular disease; DHT, dihydrotestosterone; E2, 17-β2 
estradiol; ECs, endothelial cells; eNOS, endothelial Nitric Oxide Synthase; HUVEC, human 
umbilical vein endothelial cell; SM, standard medium; VEGF, Vascular Endothelial Growth 
Factor.  
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suggest that one or more substances removed from serum by stripping procedure (and 
different from sex hormones) are crucially required for HUVEC growth and sprouting. 
Therefore, caution should be used in interpreting results when ECs are studied in CS 
serum-containing media.  
Materials and methods 
Cell cultures  
HUVECs were isolated from freshly derived umbilical cords by collagenase digestion as 
described by Jaffe et al. (13). Cells were routinely grown in 199 medium supplemented 
with 20% fetal bovine serum (FBS), 25 µg/ml endothelial cell growth supplement (ECGS), 
and 50 µg/ml heparin, and used at passages 1-3. ECGS is an extract of bovine neural 
tissue containing growth factors for mammalian ECs (Sigma Aldrich, product number 
E2759). Notably, we always used HUVECs pooled from two or more donors to minimize 
the variability associated with cells derived from a single newborn donor. Umbilical cords 
were donated anonymously after informed consent according to national ethical 
legislation. Charcoal stripping of FBS was performed following standard protocols (11). All 
the experiments were performed on cells plated on 0.1% gelatin-coated surfaces. When 
sex hormones were tested, a corresponding concentration of vehicle (ethanol) was added 
to control samples.   
Cell metabolism assays 
Cell metabolism was assessed by the MTT tetrazolium reduction assay and by measuring 
the total cellular ATP with a CellTiter-Glo® Luminescent assay (Promega). All assays were 
performed according to the manufacturer’s instructions on HUVECs plated at a density of 
2x104 cells/well in 96-well microplates. Optical density at 570 nm (for MTT) and 
luminescence (for ATP) were measured by using a multi-plate spectrophotometer 
(Victor™, PerkinElmer). All the experiments were run in triplicate.  
Evaluation of cell number and viability 
Cell number and viability were assessed by the trypan blue exclusion test. Quantification 
of apoptosis/necrosis was performed by the Annexin V-FITC conjugate and propidium 
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iodide (PI) staining (Abcam) followed by fluorescence activated cell sorting (FACS) 
performed with a FACScalibur flow cytometer equipped with a 488 nm argon laser (Becton 
Dickinson). The collected data were evaluated by Cell Quest software.  
Three-dimensional (3-D) spheroid sprouting assay  
EC spheroids of a defined cell number were embedded into collagen gels in the presence 
of 25 ng/ml VEGF as previously described (14, 15). Spheroid-containing gels were 
incubated at 37°C in 5% CO2, and 24 h later images were acquired with a phase-contrast 
microscope (10x objective magnification, Olympus U-CMAD3) equipped with an Olympus 
digital camera. In-gel angiogenesis was quantified by measuring the number and length of 
all of the capillary-like sprouts originating from individual spheroids using the National 
Institute of Health (NIH) Image J program. At least 10 randomly selected spheroids per 
experimental group were measured in each experiment.  
Reagents and Antibodies 
All tissue culture reagents were from Euroclone SpA except FBS (PAA Laboratories), ECGS 
and heparin (Sigma Aldrich). Charcoal, dextran T-70, MTT, trypan blue and 
methylcellulose (product number M0512) were from Sigma Aldrich; rat tail collagen I from 
Serva; recombinant human VEGF165 from Peprotech; E2 and DHT from Cayman Chemical.  
Statistical procedures 
Unless otherwise indicated, data are the mean ± s.e.m of at least 3 independent 
experiments. Statistical significance was determined by unpaired Student's t-test or one-
way analysis of variance (ANOVA) followed by Bonferroni’s multiple comparison test using 
the GraphPad Prism version 5.00 software.  
Results 
Effects of hormone deprivation on metabolic activity and cell number  
A crucial issue in endothelial patho-physiology concerns estrogens and their involvement 
in the sex-related incidence of cardiovascular pathologies (1, 2). To study the contribution 
of estrogens to in vitro EC behavior, we compared metabolic properties of HUVECs grown 
in a Standard Medium (199 medium w/phenol red supplemented with 10% normal FBS, 
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SM) or in a nominally estrogen-free medium (199 medium w/out phenol red 
supplemented with 10% CS-FBS, Charcoal Medium, ChM) commonly used for in vitro 
studies on hormone activities. HUVECs were cultured for 48h in SM or ChM, then fresh 
media were added, and metabolic activities were measured after a further 48h-incubation. 
In the absence of estrogens, MTT absorbance (Fig. 1A) and ATP levels (Fig. 1B) were 
significantly reduced in comparison to SM. To elucidate if decreases in MTT and ATP were 
merely dependent on a failure in metabolic activity or were vice versa consequent to a 
reduced cell growth, the number of HUVECs in the different experimental conditions was 
measured and a significant reduction in cells cultured in ChM was found (Fig. 1C). 
However, the loss in cell number did not depend on ChM-induced apoptosis and/or 
necrosis. Their quantification by annexin V-conjugated FITC and PI staining followed by 
FACS analysis did not show any significant difference neither in the apoptotic index nor in 
the percentage of necrotic cells (Fig. 1D).  
Sex hormones do not reverse the decrease in metabolic activity and cell number  
By using an add-back approach, we tested if estrogens were able to counteract the 
inhibitory effects observed in HUVECs cultured in ChM. The addition of 17-β2 estradiol (E2, 
1 nM) for the last 48h of incubation left unaffected the ChM-induced decrease in MTT 
absorbance (Fig. 2A). Super imposable results were obtained by measuring the total 
cellular ATP (Fig. 2B) and the number of cells (Fig. 2C). Since the stripping procedure 
removes sex hormones other than E2 from serum, we checked the effect of ChM 
supplementation with dihydrotestosterone (DHT, 1 nM) and found that it did not reverse 
the decrease in MTT absorbance (Fig. 2D). Likewise, the simultaneous addition of E2 and 
DHT (both at a 1 nM concentration) left unaffected the reduced MTT absorbance (Fig. 
2D). Also the treatment with higher concentrations of E2 and/or DHT (10 nM) did not 
modify these results (data not shown). On the contrary, HUVECs were able to fully recover 
their metabolic activity when SM was added instead of hormones for the last 48h of 
incubation (Fig. 2E). All together, these results demonstrate that HUVECs underwent a 
significant decrease in cell number (and consequently in metabolic activity) without any 
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apparent cell death when cultured in a phenol red-free medium supplemented with CS-
FBS. Importantly, this reduction was independent of the presence of E2 and/or DHT 
regardless of the described expression of their receptors in HUVECs (16).  
Effects of CS-FBS on metabolic activity and cell number  
Our results suggest that the decrease in metabolic activity and cell number observed in 
HUVECs cultured in ChM was not related to the lack of sex hormones. Moreover, since 
HUVECs cultured in 199 medium w/out phenol red supplemented with 10% normal FBS 
(SM w/out phenol red) did not show any difference in MTT absorbance when compared to 
HUVECs grown in SM (Fig. 3A), we also excluded the involvement of phenol red and of its 
estrogenic properties (10). Consequently, we focused our attention on FBS by comparing 
cells grown in SM with cells cultured in 199 medium containing phenol red and 10% CS-
FBS (ChM w/phenol red). Importantly, we submit to the stripping procedure exactly the 
same lot of serum present in SM. Therefore, in this experimental setting, HUVECs were 
exposed to growth media that differ only for FBS components. The presence of CS-FBS 
was sufficient to induce a significant decrease in cell number (Fig. 3B) and MTT 
absorbance (Fig. 3C). Again, the addition of E2 (1 nM) did not counteract the loss in MTT 
and ATP induced by CS-FBS (Fig. 3D). Similarly, DHT was unable to reverse the MTT 
inhibition observed in the presence of CS-FBS when added alone or in combination with E2 
(data not shown). Results obtained with ChM w/phenol red suggest that one or more 
substances removed from FBS by stripping procedure and different from sex hormones 
are crucially required for HUVEC growth.  
Effect of CS-FBS on in vitro angiogenesis  
Among growth factors, Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast 
Growth Factor (bFGF) are critically involved in EC physiology, being able to induce their 
growth, migration and in vitro differentiation (17). We therefore tested if VEGF (20 ng/ml) 
and bFGF (20 ng/ml) were able to reverse the inhibitory effect of CS-FBS. The decrease in 
MTT was however maintained in the presence of the growth factors (Fig. 4A), thus 
suggesting that neither VEGF nor bFGF were the substance(s) lost in CS-FBS crucially 
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required for HUVEC growth. Furthermore, we set up a 3-D assay by embedding size- and 
cell number-defined HUVEC spheroids in a collagen gel to study in vitro angiogenesis (14, 
15). In this assay, spheroids fully retained their ability to sprout when suspended in SM 
(Figs. 4B, and 4C for quantification) whereas the outgrowth of capillary-like structures 
was significantly reduced in spheroids suspended in ChM w/phenol red or ChM (Figs. 4B, 
and 4C for quantification). These results demonstrate that EC growth and sprouting 
critically require some serum components different from VEGF and bFGF that are lost in 
CS-FBS.  
Discussion  
We started our experiments with the aim of studying the regulatory role of estrogens on 
metabolic properties in human ECs. But we found that HUVECs underwent a significant 
decrease in cell number (and consequently in metabolic activity) when cultured in a 
medium supplemented with CS-FBS commonly used for in vitro studies on hormone 
activities. Notably, ECs also lacked the ability to undergo in vitro angiogenesis in a 3-D 
spheroid assay. These results advise about the disregarded contribute of CS-FBS to data 
obtained from ECs cultured in nominally hormone-free media.  
 Charcoal-stripped serum is largely used in cellular, biological, and pharmacological 
studies. The stripping procedure reduces or depletes the concentration of many 
biologically active substances such as steroids, thyroid and peptide hormones, vitamins, 
electrolytes, enzymes, metabolites, and lipids (11, 12, 18). Some alterations in cell 
signaling and differentiation have been described in cells cultured in CS-FBS in comparison 
to their counterpart grown in normal serum (19, 20). Furthermore, the growth of human 
CFU-megacaryokytes is improved when cells are cultured in CS-FBS (21) whereas the 
mouse osteoblastic cell line MC3T3-E1 displays a limited growth and an impaired alkaline 
phosphatase expression in CS-FBS (22). Again, CS serum modifies the phospholipid 
metabolism in type II rat pneumocytes (18) and the cellular bioenergetics of breast cancer 
cells (23).  
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 Regarding ECs, various results describing the effects of sex hormones on their 
behavior have been obtained in cells cultured in media supplemented with CS-FBS. 
However, most of these studies did not refer to cell proliferation even if they involved cells 
grown in CS-FBS for at least 24-48 h (24, 25) and also when hormones different from 
estrogens were studied (26, 27).  To our knowledge, up to now no data are available on 
the direct comparison of ECs grown in normal or CS-FBS. In our experiments, we 
consistently observed a reduced EC growth when CS-FBS was used, irrespective of the 
presence of steroid hormones and phenol red. Very importantly, the presence of CS-FBS 
totally abrogates the ability of HUVEC spheroids to sprout, thus affecting a functional 
property distinctive of ECs. Further studies will be necessary to clarify if the inhibitory 
effect of CS-FBS on sprouting depends on the reduced cell growth and/or on a decrease in 
the invasive capacity of ECs. But it is important to highlight that a crucial feature of ECs is 
missed when they are cultured in CS-FBS. 
 Our data therefore suggest that one or possible more substances removed from 
FBS are crucial for the maintenance of in vitro EC distinctive properties. This hypothesis is 
strongly supported by the result showing that the re-addition of normal serum totally 
restores the metabolic activity of HUVECs previously grown in CS-FBS. Experiments are 
ongoing in our laboratory in the attempt to identify which of the various substances 
reduced or depleted from serum by charcoal treatment might have a role in the observed 
effects. Candidates are quite numerous and heterogeneous. Folic acid and vitamin B12 for 
example are reduced in CS-FBS, and exert an in vitro protective effect on ECs (28, 29). 
However, a key candidate might be thyroid hormone (TH, L-thyroxine, T4; 3,5,3′-triiodo-l-
thyronine, T3). TH plays a central role in the regulation of angiogenesis (30) by acting as 
soluble ligand on its receptor on integrin αvβ3 that is highly expressed on the membrane 
of activated ECs. Multiple mechanisms are responsible for the pro-angiogenic effect of TH 
including modulation of activities of different growth factor receptors and ligands, such as 
VEGF and bFGF, as well as of angiogenic chemokines. TH also increases the activity of 
other peptides that contribute to vessel formation such as bradikinin and angiotensin II. 
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Furthermore, since non-genomic actions initiated by the binding of TH to its receptor on 
integrin αvβ3 can finally induce expression of genes involved in angiogenesis, both non-
genomic and genomic mechanisms contribute to the pro-angiogenic properties of TH (31). 
Therefore, the absence of TH from CS-FBS might be critical for the impaired growth and 
sprouting induced by the hormone-deprived serum in ECs, thus suggesting TH as an 
excellent candidate to explain our results. Finally, metabolic pathways are emerging as 
important regulators of angiogenesis. In particular, ECs increase glycolysis while forming 
new blood vessels (32), and fatty acids have been crucially involved in the regulation of 
EC proliferation (33). Therefore, also a deficit in cell metabolism might contribute to the 
impairment of cell growth and sprouting that we observe in ECs grown in CS-FBS. 
In conclusion, our data showing that HUVECs lose a distinguishing feature (the 
sprouting ability) and modify their physiology in the presence of CS-FBS demonstrate the 
crucial role of media composition in the establishment of cellular responses. These 
observations may be part of a more general discussion on serum starvation and on its 
interfering potential with experimental results and conclusions (34). In addition to impart 
extra variables to experiments, the use of treated sera may also induce unpredictable 
changes in cellular phenotypic characteristics. For that reason, it is important to be aware 
of the underestimated contribute that CS-FBS may give to experimental outcomes in ECs, 
and possibly in other cell types.  
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Figure 1. Hormone deprivation induces a decrease in metabolic activity and cell 
number. HUVECs were cultured in SM (solid bars) or ChM (open bars), and 48h later 
fresh media were added. MTT absorbance (A), total cellular ATP (B), and cell number (C) 
were measured after further 48 h of incubation. *p<0.05 vs SM, n=4-6-3 in (A), (B), and 
(C), respectively. (D) FACS analysis using Annexin V/PI double staining. Percents of 
gated cells in each quadrant are shown (n=4). UL, necrotic cells; UR + LR, apoptotic cells; 
LL, live cells.  
Figure 2. Sex hormones do not reverse the loss in metabolic activity and cell 
number. Experiments were performed as described in Figure 1 on HUVECs cultured for 
48h in SM or ChM. During the last 48 h of incubation, media were changed, and cells in 
ChM were treated with vehicle (ethanol, open bars) or E2 (1 nM, diagonal bars) before 
measurements of MTT (A), ATP (B), and cell number (C). Data are expressed as 
percentages of control cells i.e. cells cultured in SM (solid bar). ***p<0.001, **p<0.01, 
*p<0.05 vs SM, ns vs ChM + vehicle, n=9-5-3 in (A), (B), and (C), respectively. In (D), 
vehicle (open bar), E2 (1 nM, diagonal bar), DHT (1 nM, horizontal bar), or E2 + DHT 
(grey bar) were added to ChM as described above. **p<0.001 vs SM, ns vs ChM + 
vehicle, n=3. (E) ChM was replaced with SM for the last 48h of incubation (ChM/SM, 
squared bar). ***p<0.001 vs SM, p<0.001 vs ChM, n=3. 
Figure 3. CS-FBS is sufficient to induce a decrease in metabolic activity and cell 
number. (A) MTT absorbance was measured after 48h of incubation in SM (solid bar) or 
SM w/out phenol red (pointed bar). ns vs SM, n=7. Cell number (B) and  MTT (C) were 
measured after 48h of incubation in SM (solid bars), ChM w/phenol red (cross-hitched 
bars) or ChM (open bars). *p<0.05, **p<0.01 vs SM, no significant differences between 
ChM w/phenol red and ChM, One-way ANOVA with Bonferroni’s test,  n=4-10 in (B) and 
(C), respectively. (D) MTT (left axis) and ATP (right axis) were measured after 48h of 
incubation in SM (solid bars), in ChM w/phenol red + vehicle (cross-hitched bars), or in 
ChM w/phenol red + E2 (1 nM, diagonal bars). *p<0.05 vs SM, ns vs ChM + vehicle, n=3. 
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Figure 4. Effect of CS-FBS on in vitro angiogenesis. (A) HUVECs were cultured for 
48h in SM (solid bars), ChM w/phenol red (cross-hitched bars) or ChM (open bar) in the 
absence or in the presence of VEGF and bFGF (both at 20 ng/ml). ***p<0.001 vs SM,  ns 
vs ChM w/phenol red or ChM, n=3. (B) Representative images of HUVEC spheroids 
embedded in collagen gels in the presence of SM (upper panel), ChM w/phenol red 
(middle panel) or ChM (lower panel). Photographs were taken 24 h later. (C) 
Quantification of the number of sprouts (left axis) and of the cumulative sprouting length 
(right axis) emerging from 12-15 individual spheroids per experimental group in a 
representative experiment repeated three times. ***p<0.001 vs SM, One-way ANOVA 
with Bonferroni’s test.  
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Figure 1. Hormone deprivation induces a decrease in metabolic activity and cell number. HUVECs were 
cultured in SM (solid bars) or ChM (open bars), and 48h later fresh media were added. MTT absorbance (A), 
total cellular ATP (B), and cell number (C) were measured after further 48 h of incubation. *p<0.05 vs SM, 
n=4-6-3 in (A), (B), and (C), respectively. (D) FACS analysis using Annexin V/PI double staining. Percents of 
gated cells in each quadrant are shown (n=4). UL, necrotic cells; UR + LR, apoptotic cells; LL, live cells.  
108x68mm (300 x 300 DPI)  
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Figure 2. Sex hormones do not reversed the loss in metabolic activity and cell number. Experiments were 
performed as described in Figure 1 on HUVECs cultured for 48h in SM or ChM. During the last 48 h of 
incubation, media were changed, and cells in ChM were treated with vehicle (ethanol, open bars) or E2 (1 
nM, diagonal bars) before measurements of MTT (A), ATP (B), and cell number (C). Data are expressed as 
percentages of control cells i.e. cells cultured in SM (solid bar). ***p<0.001, **p<0.01, *p<0.05 vs SM, ns 
vs ChM + vehicle, n=9-5-3 in (A), (B), and (C), respectively. In (D), vehicle (open bar), E2 (1 nM, diagonal 
bar), DHT (1 nM, horizontal bar), or E2 + DHT (grey bar) were added to ChM as described above. 
**p<0.001 vs SM, ns vs ChM + vehicle, n=3. (E) ChM was replaced with SM for the last 48h of incubation 
(ChM/SM, squared bar). ***p<0.001 vs SM, p<0.001 vs ChM, n=3.  
139x112mm (300 x 300 DPI)  
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Figure 3. CS-FBS is sufficient to induce a decrease in metabolic activity and cell number. (A) MTT 
absorbance was measured after 48h of incubation in SM (solid bar) or SM w/out phenol red (pointed bar). ns 
vs SM, n=7. Cell number (B) and  MTT (C) were measured after 48h of incubation in SM (solid bars), ChM 
w/phenol red (cross-hitched bars) or ChM (open bars). *p<0.05, **p<0.01 vs SM, no significant differences 
between ChM w/phenol red and ChM, One-way ANOVA with Bonferroni’s test,  n=4-10 in (B) and (C), 
respectively. (D) MTT (left axis) and ATP (right axis) were measured after 48h of incubation in SM (solid 
bars), in ChM w/phenol red + vehicle (cross-hitched bars), or in ChM w/phenol red + E2 (1 nM, diagonal 
bars). *p<0.05 vs SM, ns vs ChM + vehicle, n=3.  
104x63mm (300 x 300 DPI)  
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Figure 4. Effect of CS-FBS on in vitro angiogenesis. (A) HUVECs were cultured for 48h in SM (solid bars), 
ChM w/phenol red (cross-hitched bars) or ChM (open bar) in the absence or in the presence of VEGF and 
bFGF (both at 20 ng/ml). ***p<0.001 vs SM,  ns vs ChM w/phenol red or ChM, n=3. (B) Representative 
images of HUVEC spheroids embedded in collagen gels in the presence of SM (upper panel), ChM w/phenol 
red (middle panel) or ChM (lower panel). Photographs were taken 24 h later. (C) Quantification of the 
number of sprouts (left axis) and of the cumulative sprouting length (right axis) emerging from 12-15 
individual spheroids per experimental group in a representative experiment repeated three times. 
***p<0.001 vs SM, One-way ANOVA with Bonferroni’s test.  
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